Palonosetron and Ganciclovir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Palonosetron (palonosetron hydrochloride) and Ganciclovir (ganciclovir). Common drug interactions include platelet count decreased among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Palonosetron and Ganciclovir. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Palonosetron?

Palonosetron has active ingredients of palonosetron hydrochloride. eHealthMe is studying from 5,962 Palonosetron users. Check the latest studies of Palonosetron.

What is Ganciclovir?

Ganciclovir has active ingredients of ganciclovir. eHealthMe is studying from 6,370 Ganciclovir users. Check the latest studies of Ganciclovir.

On Jul, 19, 2026

18 people who take Palonosetron and Ganciclovir together, and have interactions are studied.

Palonosetron and Ganciclovir drug interactions.

What are the common drug interactions of Palonosetron and Ganciclovir, by gender? *:

female:

Platelet count decreased
Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Abdominal discomfort
Alanine aminotransferase increased
Anaemia (lack of blood)
Arrhythmia (irregular heartbeat)
Aspartate aminotransferase increased
Asthenia (weakness)
Back pain
Bilirubin conjugated increased

male:

Abdominal pain
Alpha hydroxybutyrate dehydrogenase increased
Decreased appetite
Dizziness
Hypercalcaemia (elevated calcium (ca+) level in the blood)
Hypokalaemia (low potassium)
Hypoproteinaemia (too little prolactin circulating in the blood)
Lymphocyte count decreased
Nausea (feeling of having an urge to vomit)
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)

What are the common drug interactions of Palonosetron and Ganciclovir, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Platelet count decreased
Abdominal discomfort
Alanine aminotransferase increased
Anaemia (lack of blood)
Arrhythmia (irregular heartbeat)
Aspartate aminotransferase increased
Asthenia (weakness)
Back pain
Bilirubin conjugated increased
Blood alkaline phosphatase increased

50-59:

Platelet count decreased
Interstitial lung disease
Cytomegalovirus infection
Drug ineffective
Hepatic failure (liver failure)
Respiratory failure (inadequate gas exchange by the respiratory system)
Sepsis (a severe blood infection that can lead to organ failure and death)

60+:

Abdominal pain
Alpha hydroxybutyrate dehydrogenase increased
Decreased appetite
Dizziness
Hypercalcaemia (elevated calcium (ca+) level in the blood)
Hypokalaemia (low potassium)
Hypoproteinaemia (too little prolactin circulating in the blood)
Lymphocyte count decreased
Nausea (feeling of having an urge to vomit)
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)

What are the existing conditions these people have? *

Neuropathy Peripheral (surface nerve damage): 8 people, 44.44%
Liver Disorder (liver diseases): 8 people, 44.44%
Multiple Myeloma (cancer of the plasma cells): 8 people, 44.44%
Constipation: 6 people, 33.33%
Pneumonia: 6 people, 33.33%
Hypersensitivity: 6 people, 33.33%
White Blood Cell Count Decreased: 5 people, 27.78%
Anaemia (lack of blood): 5 people, 27.78%
Bone Disorder: 5 people, 27.78%
Cytomegalovirus Infection: 5 people, 27.78%

* Approximation only. Some reports may have incomplete information.

Do you take Palonosetron and Ganciclovir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously